Effects of CYP2D6 *10 and *41 Variants in Healthy Chinese Men on the Pharmacokinetics of Dapoxetine
The Journal of Clinical Pharmacology · 2024
DOI: 10.1002/jcph.2391 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, 2024. Verfasst von Zhipeng Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy Lanzhou University, Lanzhou, Gansu, China. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2D6, Benzylamines, Naphthalenes, Selective Serotonin Reuptake Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Dapoxetine is a selective serotonin reuptake inhibitor (SSRI) used to treat premature ejaculation (PE), and is mainly metabolized by CYP2D6 , CYP3A4 , and flavin‐containing monooxygenase 1. The purpose of the study was to evaluate the effect of CYP2D6 polymorphism on the pharmacokinetics of dapoxetine in healthy Chinese men. Thirty‐nine subjects who received a single oral dose of 30 mg dapoxetine hydrochloride were classified based on their CYP2D6 genotype: *1/*1 (n = 9), *1/*41 (n = 1), *1/*10 (n = 12), *10/*41 (n = 3), or *10/*10 (n = 14). The difference in pharmacokinetic parameters between different genotype groups was analyzed and then scored according to the activity score system. Compared with the wild‐type subjects of CYP2D6 *1/*1 , the peak plasma concentration (C max ) and the area under the plasma drug concentration‐time curve (AUC inf ) of dapoxetine in the *10/*10 and *10/*41 groups were notably increased ( P ≤ .05). Significant differences in C max , AUC, volume of distribution/bioavailability (V/F) and clearance/bioavailability (CL/F) were observed among dapoxetine activity score groups ( P ≤ .05). The AUC inf was increased significantly (154% and 89.73%, P ≤ .05) and the C max was increased significantly (73.45% and 42.67%, P ≤ .05) in CYP2D6 *10/*41 subjects, compared with CYP2D6 *1/*1 and *1/*10 subjects. The results obtained indicated that CYP2D6 *10 and *41 polymorphisms have significant effects on the pharmacokinetic properties of dapoxetine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy Lanzhou University, Lanzhou, Gansu, China.
- National Drug Clinical Trial Institution, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
- Pharmacy Department, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
Zitieren
APA
Wang, Z., Gao, Y., Ji, X., Wu, T., Pu, L., & Qiu, W. (2024). Effects of CYP2D6 *10 and *41 Variants in Healthy Chinese Men on the Pharmacokinetics of Dapoxetine. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.2391
Vancouver
Wang Z, Gao Y, Ji X, Wu T, Pu L, Qiu W. Effects of CYP2D6 *10 and *41 Variants in Healthy Chinese Men on the Pharmacokinetics of Dapoxetine. The Journal of Clinical Pharmacology. 2024. doi:10.1002/jcph.2391
BibTeX
@article{Wang2024,
author = {Wang, Zhipeng and Gao, Yuan and Ji, Xingfang and Wu, Tong and Pu, Libin and Qiu, Wen},
title = {Effects of CYP2D6 *10 and *41 Variants in Healthy Chinese Men on the Pharmacokinetics of Dapoxetine},
journal = {The Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1002/jcph.2391}
}
EUVIMED